EGFR+ Non-Small Cell Lung Cancer

FDA Grants Accelerated Approval of Sunvozertinib for Metastatic EGFR-Positive NSCLC
The approval is for adults who have experienced disease progression on or after platinum-based chemotherapy.
Advertisement
Advertisement